252 related articles for article (PubMed ID: 15894195)
1. Economic burden of osteoporosis, breast cancer, and cardiovascular disease among postmenopausal women in an employed population.
Sasser AC; Rousculp MD; Birnbaum HG; Oster EF; Lufkin E; Mallet D
Womens Health Issues; 2005; 15(3):97-108. PubMed ID: 15894195
[TBL] [Abstract][Full Text] [Related]
2. The economic consequences of irritable bowel syndrome: a US employer perspective.
Leong SA; Barghout V; Birnbaum HG; Thibeault CE; Ben-Hamadi R; Frech F; Ofman JJ
Arch Intern Med; 2003 Apr; 163(8):929-35. PubMed ID: 12719202
[TBL] [Abstract][Full Text] [Related]
3. Assessing the economic burden of breast cancer in a US managed care population.
Barron JJ; Quimbo R; Nikam PT; Amonkar MM
Breast Cancer Res Treat; 2008 May; 109(2):367-77. PubMed ID: 17674201
[TBL] [Abstract][Full Text] [Related]
4. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients.
Michaud K; Messer J; Choi HK; Wolfe F
Arthritis Rheum; 2003 Oct; 48(10):2750-62. PubMed ID: 14558079
[TBL] [Abstract][Full Text] [Related]
5. Economic cost and epidemiological characteristics of patients with fibromyalgia claims.
Robinson RL; Birnbaum HG; Morley MA; Sisitsky T; Greenberg PE; Claxton AJ
J Rheumatol; 2003 Jun; 30(6):1318-25. PubMed ID: 12784409
[TBL] [Abstract][Full Text] [Related]
6. Estimates of the direct cost per case and overall burden of trichomoniasis for the employer-sponsored privately insured women population in the United States, 2001 to 2005.
Owusu-Edusei K; Tejani MN; Gift TL; Kent CK; Tao G
Sex Transm Dis; 2009 Jun; 36(6):395-9. PubMed ID: 19556934
[TBL] [Abstract][Full Text] [Related]
7. Economic costs of benign prostatic hyperplasia in the private sector.
Saigal CS; Joyce G
J Urol; 2005 Apr; 173(4):1309-13. PubMed ID: 15758787
[TBL] [Abstract][Full Text] [Related]
8. The direct medical cost of cardiovascular diseases, hypertension, diabetes, cancer, pregnancy and female infertility in a large HMO in Israel.
Chodick G; Porath A; Alapi H; Sella T; Flash S; Wood F; Shalev V
Health Policy; 2010 May; 95(2-3):271-6. PubMed ID: 20061044
[TBL] [Abstract][Full Text] [Related]
9. Health care utilization and costs of adult cardiovascular conditions United States, 1980.
Harlan WR; Parsons PE; Thomas JW; Murt HA; Lepkowski JM; Guire KE; Berki SE; Landis JR
Natl Med Care Util Expend Surv C; 1989 Nov; (7):iii-iv, 1-71. PubMed ID: 10313477
[TBL] [Abstract][Full Text] [Related]
10. Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000.
Chang S; Long SR; Kutikova L; Bowman L; Finley D; Crown WH; Bennett CL
J Clin Oncol; 2004 Sep; 22(17):3524-30. PubMed ID: 15337801
[TBL] [Abstract][Full Text] [Related]
11. The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database.
Joish VN; Donaldson G; Stockdale W; Oderda GM; Crawley J; Sasane R; Joshua-Gotlib S; Brixner DI
Curr Med Res Opin; 2005 Apr; 21(4):535-44. PubMed ID: 15899102
[TBL] [Abstract][Full Text] [Related]
12. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
13. Health and economic burden of metabolic comorbidity among individuals with bipolar disorder.
Centorrino F; Mark TL; Talamo A; Oh K; Chang J
J Clin Psychopharmacol; 2009 Dec; 29(6):595-600. PubMed ID: 19910727
[TBL] [Abstract][Full Text] [Related]
14. Costs of physical and mental comorbidities among employees: a comparison of those with and without bipolar disorder.
Rajagopalan K; Kleinman NL; Brook RA; Gardner HH; Brizee TJ; Smeeding JE
Curr Med Res Opin; 2006 Mar; 22(3):443-52. PubMed ID: 16574028
[TBL] [Abstract][Full Text] [Related]
15. Economic burden and co-morbidities of atrial fibrillation in a privately insured population.
Wu EQ; Birnbaum HG; Mareva M; Tuttle E; Castor AR; Jackman W; Ruskin J
Curr Med Res Opin; 2005 Oct; 21(10):1693-9. PubMed ID: 16238910
[TBL] [Abstract][Full Text] [Related]
16. Depression and fibromyalgia: treatment and cost when diagnosed separately or concurrently.
Robinson RL; Birnbaum HG; Morley MA; Sisitsky T; Greenberg PE; Wolfe F
J Rheumatol; 2004 Aug; 31(8):1621-9. PubMed ID: 15290744
[TBL] [Abstract][Full Text] [Related]
17. An employer perspective on annual employee and dependent costs for pediatric asthma.
Kleinman NL; Brook RA; Ramachandran S
Ann Allergy Asthma Immunol; 2009 Aug; 103(2):114-20. PubMed ID: 19739423
[TBL] [Abstract][Full Text] [Related]
18. Economic burden associated with breast cancer recurrence: findings from a retrospective analysis of health system data.
Lamerato L; Havstad S; Gandhi S; Jones D; Nathanson D
Cancer; 2006 May; 106(9):1875-82. PubMed ID: 16572409
[TBL] [Abstract][Full Text] [Related]
19. The economic burden of rheumatoid arthritis in a developing nation: results from a one-year prospective cohort study in Thailand.
Osiri M; Maetzel A; Tugwell P
J Rheumatol; 2007 Jan; 34(1):57-63. PubMed ID: 17183621
[TBL] [Abstract][Full Text] [Related]
20. Cost of gastro-oesophageal reflux disease to the employer: a perspective from the United States.
Brook RA; Wahlqvist P; Kleinman NL; Wallander MA; Campbell SM; Smeeding JE
Aliment Pharmacol Ther; 2007 Sep; 26(6):889-98. PubMed ID: 17767473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
